New Strategy to Develop Personalized Cancer Immunotherapies Highlighted in Study
News
In a new study entitled “Mutant MHC class II epitopes drive therapeutic immune responses to cancer,” researchers report the foundations of a new strategy to develop personalized cancer immunotherapies based ... Read more